Role of Cryptosporidium Mucins in Host-parasite interactions
隐孢子虫粘蛋白在宿主-寄生虫相互作用中的作用
基本信息
- 批准号:7168031
- 负责人:
- 金额:$ 20.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-06-15 至 2008-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Cryptosporidium is a ubiquitous waterborne pathogen that causes diarrheal disease worldwide. This pathogen is of significant medical importance because of its capacity to cause life-threatening diarrheal disease in immunocompromised hosts, particularly AIDS patients. To date there is no consistently effective treatment for Cryptosporidium infection, and no vaccine to prevent infection. Studies suggest that Cryptosporidium, unlike other apicomplexans, relies on mucin-like glycoproteins to attach to and invade intestinal epithelial cells. These mucin antigens are also targets of protective cellular immune responses. Despite the importance of mucin antigens to Cryptosporidium biology, few of these antigens have been investigated. The Cryptosporidium genome project has identified 31 open reading frames encoding putative mucin antigens. The studies proposed in this application will investigate 7 mucins that reside on a single locus on chromosome 2 (CpMuc1-7) and determine the role they play in host-parasite interactions. Aim #1: To characterize expression, localization, post-translational modifications, and potential multi-protein complex formation of the seven mucin-like glycoproteins of the CpMuc1-7 locus. We will quantify expression of the CpMucs during intracellular development using real-time RT-PCR, determine protein expression and localization, elucidate the glycosylation patterns of the native antigens, and determine if these antigens form multi-protein complexes. Aim #2: To determine if the CpMuc1-7 glycoproteins play a role in invasion and/or stimulation of cell mediated immune responses. We will determine if anti-CpMuc antibodies and recombinant proteins inhibit C. parvum invasion of intestinal epithelial cells, and determine if the CpMucs are activators of cellular immune responses that develop during infection in mice. In these studies, we will also explore the effect of glycosylation in host cell invasion and immune activation. Finally, employing a non-virulent T. gondii strain as an antigen delivery system, we will determine if immune responses targeted against one of the CpMucs provides protection from cryptosporidiosis. These studies will enhance our understanding of the role mucin-like glycoproteins play in the establishment and resolution of Cryptosporidium infections and greatly advance our ability to design effective treatments to combat this serious infectious threat around the world.
描述(申请人提供):隐孢子虫是一种普遍存在的水传播病原体,可在世界范围内引起腹泻疾病。这种病原体具有重要的医学意义,因为它能够在免疫受损的宿主,特别是艾滋病患者中引起危及生命的腹泻疾病。到目前为止,还没有持续有效的治疗隐孢子虫感染的方法,也没有预防感染的疫苗。研究表明,隐孢子虫与其他顶端复合体不同,它依赖粘蛋白样糖蛋白附着和入侵肠道上皮细胞。这些粘蛋白抗原也是保护性细胞免疫反应的目标。尽管粘蛋白抗原对隐孢子虫的生物学很重要,但很少有人对其进行研究。隐孢子虫基因组计划已经确定了31个开放阅读框,编码假定的粘蛋白抗原。这项申请中提出的研究将研究位于2号染色体(CpMuc1-7)上的7个粘蛋白,并确定它们在宿主-寄生虫相互作用中所起的作用。目的#1:研究CpMuc1-7基因座7个粘蛋白样糖蛋白的表达、定位、翻译后修饰和潜在的多蛋白复合体形成。我们将使用实时定量RT-PCR来定量CpMucs在细胞内发育过程中的表达,确定蛋白质的表达和定位,阐明天然抗原的糖基化模式,并确定这些抗原是否形成多蛋白复合体。目的#2:确定CpMuc1-7糖蛋白是否在细胞免疫反应的侵袭和/或刺激中发挥作用。我们将确定抗CpMuc抗体和重组蛋白是否抑制微小弧菌对肠道上皮细胞的入侵,并确定CpMucs是否是小鼠感染期间发展的细胞免疫反应的激活剂。在这些研究中,我们还将探索糖基化在宿主细胞侵袭和免疫激活中的作用。最后,使用非毒力弓形虫株作为抗原传递系统,我们将确定针对其中一种CpMucs的免疫反应是否提供了对隐孢子虫病的保护。这些研究将加深我们对粘蛋白样糖蛋白在隐孢子虫感染的建立和解决中所起的作用的理解,并极大地提高我们设计有效的治疗方法来对抗世界各地这一严重的传染病威胁的能力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERTA M O'CONNOR其他文献
ROBERTA M O'CONNOR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERTA M O'CONNOR', 18)}}的其他基金
Antiparasitic metabolites from deep subterranean fungi for the treatment of cryptosporidiosis, an AIDS defining disease
来自深层地下真菌的抗寄生虫代谢物用于治疗隐孢子虫病(一种艾滋病定义的疾病)
- 批准号:
10698574 - 财政年份:2023
- 资助金额:
$ 20.21万 - 项目类别:
Development of a new marine natural product for the treatment of cryptosporidiosis, an AIDS-defining disease
开发一种新的海洋天然产品来治疗隐孢子虫病(一种艾滋病定义的疾病)
- 批准号:
10495750 - 财政年份:2020
- 资助金额:
$ 20.21万 - 项目类别:
Development of a new marine natural product for the treatment of cryptosporidiosis, an AIDS-defining disease
开发一种新的海洋天然产品来治疗隐孢子虫病(一种艾滋病定义的疾病)
- 批准号:
10402287 - 财政年份:2020
- 资助金额:
$ 20.21万 - 项目类别:
Development of a new marine natural product for the treatment of cryptosporidiosis, an AIDS-defining disease
开发一种新的海洋天然产品来治疗隐孢子虫病(一种艾滋病定义的疾病)
- 批准号:
10631912 - 财政年份:2020
- 资助金额:
$ 20.21万 - 项目类别:
Development of a new marine natural product for the treatment of cryptosporidiosis, an AIDS-defining disease
开发一种新的海洋天然产品来治疗隐孢子虫病(一种艾滋病定义的疾病)
- 批准号:
10076207 - 财政年份:2020
- 资助金额:
$ 20.21万 - 项目类别:
Investigation of a shipworm endosymbiont compound with activity against the AIDS-associated pathogens Cryptosporidium and Toxoplasma
对具有抗艾滋病相关病原体隐孢子虫和弓形虫活性的船虫内共生化合物的研究
- 批准号:
9267939 - 财政年份:2017
- 资助金额:
$ 20.21万 - 项目类别:
Investigation of a shipworm endosymbiont compound with activity against the AIDS-associated pathogens Cryptosporidium and Toxoplasma
对具有抗艾滋病相关病原体隐孢子虫和弓形虫活性的船虫内共生化合物的研究
- 批准号:
9431036 - 财政年份:2017
- 资助金额:
$ 20.21万 - 项目类别:
T. gondii as a model for investigation of Cryptosporidium glycoprotein antigens
弓形虫作为研究隐孢子虫糖蛋白抗原的模型
- 批准号:
8111486 - 财政年份:2010
- 资助金额:
$ 20.21万 - 项目类别:
T. gondii as a model for investigation of Cryptosporidium glycoprotein antigens
弓形虫作为研究隐孢子虫糖蛋白抗原的模型
- 批准号:
7756965 - 财政年份:2009
- 资助金额:
$ 20.21万 - 项目类别:
T. gondii as a model for investigation of Cryptosporidium glycoprotein antigens
弓形虫作为研究隐孢子虫糖蛋白抗原的模型
- 批准号:
7893819 - 财政年份:2009
- 资助金额:
$ 20.21万 - 项目类别:
相似国自然基金
Neo-antigens暴露对肾移植术后体液性排斥反应的影响及其机制研究
- 批准号:2022J011295
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
结核分枝杆菌持续感染期抗原(latency antigens)的重组BCG疫苗研究
- 批准号:30801055
- 批准年份:2008
- 资助金额:19.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Strategies for next-generation flavivirus vaccine development
下一代黄病毒疫苗开发策略
- 批准号:
10751480 - 财政年份:2024
- 资助金额:
$ 20.21万 - 项目类别:
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 20.21万 - 项目类别:
B Cell Epitope Discovery and Mechanisms of Antibody Protection: Responses to Dengue 4, Powassan, Chikungunya, and Venezuelan Equine Encephalitis Viruses
B 细胞表位发现和抗体保护机制:对登革热 4、Powassan、基孔肯雅热和委内瑞拉马脑炎病毒的反应
- 批准号:
10909763 - 财政年份:2023
- 资助金额:
$ 20.21万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 20.21万 - 项目类别:
Probing functional HIV-1 envelope glycoprotein conformations with novel potent CD4-mimetic compounds
用新型有效的 CD4 模拟化合物探测功能性 HIV-1 包膜糖蛋白构象
- 批准号:
10762703 - 财政年份:2023
- 资助金额:
$ 20.21万 - 项目类别:
Precision Glycoengineering of an HCV Envelope-Based Nanoparticle Vaccine
HCV 包膜纳米颗粒疫苗的精密糖工程
- 批准号:
10759994 - 财政年份:2023
- 资助金额:
$ 20.21万 - 项目类别:
Anti-flavivirus B cell response analysis to aid vaccine design
抗黄病毒 B 细胞反应分析有助于疫苗设计
- 批准号:
10636329 - 财政年份:2023
- 资助金额:
$ 20.21万 - 项目类别:
Developing a PIV5-based human metapneumovirus (HMPV) vaccine
开发基于 PIV5 的人类偏肺病毒 (HMPV) 疫苗
- 批准号:
10698491 - 财政年份:2023
- 资助金额:
$ 20.21万 - 项目类别:
Programming designer DNA nanostructures for blocking enveloped viral infection
编程设计 DNA 纳米结构以阻止包膜病毒感染
- 批准号:
10598739 - 财政年份:2023
- 资助金额:
$ 20.21万 - 项目类别:
Combining Molecular Simulations and Biophysical Methods to Characterize Conformational Dynamics of the HIV-1 Envelope Glycoprotein
结合分子模拟和生物物理方法来表征 HIV-1 包膜糖蛋白的构象动力学
- 批准号:
10749273 - 财政年份:2023
- 资助金额:
$ 20.21万 - 项目类别: